WG
ALT icon

Welch Group’s Altimmune ALT Stock Holding History

Welch Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,000
Closed -$13K – 149
2018
Q2 		$13K Buy
+1,000
New +$19.7K ﹤0.01% 139

Other funds holding ALT

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Welch Group's ALT Position: Q3 2018 in Review

Welch Group sold out of Altimmune (ALT) in Q3 2018, closing a stake of 1,000 shares — an estimated $13K sold.

Welch Group first reported a position in ALT in Q2 2018 and held it in 1 quarter. The position peaked at $13K in Q2 2018. 16 funds tracked by Wall St. Rank hold ALT as of Q3 2018.

  • Welch Group reported no remaining Altimmune position as of Q3 2018 after selling out during the quarter.
  • Welch Group sold 1,000 Altimmune shares in Q3 2018, an estimated $13K.
  • Welch Group first reported a position in Altimmune in Q2 2018 and held it in 1 quarter.
  • Welch Group's Altimmune position peaked at $13K in Q2 2018.
  • 16 funds tracked by Wall St. Rank held Altimmune as of Q3 2018.

Based on Welch Group's 13F filing for Q3 2018, filed 1 Nov 2018.